(1)
EVALUATION OF THE PRESCRIPTION PATTERNS OF ANTITUBERCULAR DRUGS AND ASSESSMENT OF DRUG UTILIZATION USING WHO CORE PRESCRIBING INDICATORS. Int. Res. J. Pharm. 2026, 17 (9), 1-10. https://doi.org/10.56802/k8x24732.